EUVIMEDEUVIMED entdecken
Open Access

Metabolic Usage and Glycan Destinations of GlcNAz in E. coli

Alexander Eddenden iD, Manoj K Dooda, Zachary A Morrison, Adithya Shankara Subramanian, P Lynne Howell, Jerry M Troutman iD, Mark Nitz iD

ACS Chemical Biology · 2024

DOI: 10.1021/acschembio.3c00501 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Biology, 2024. Verfasst von Alexander Eddenden und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Toronto, Toronto, Ontario M5S 3H6, Canada. Hauptthemen laut MEDLINE: Escherichia coli, Lipopolysaccharides. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Canadian Institutes of Health Research, University of Toronto.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacteria use a diverse range of carbohydrates to generate a profusion of glycans, with amino sugars, such as N-acetylglucosamine (GlcNAc), being prevalent in the cell wall and in many exopolysaccharides. The primary substrate for GlcNAc-containing glycans, UDP-GlcNAc, is the product of the bacterial hexosamine pathway and a key target for bacterial metabolic glycan engineering. Using the strategy of expressing NahK, to circumvent the hexosamine pathway, it is possible to directly feed the analogue of GlcNAc, N-azidoacetylglucosamine (GlcNAz), for metabolic labeling in Escherichia coli. The cytosolic production of UDP-GlcNAz was confirmed by using fluorescence-assisted polyacrylamide gel electrophoresis. The key question of where GlcNAz is incorporated was interrogated by analyzing potential sites including peptidoglycan (PGN), the biofilm-related exopolysaccharide poly-β-1,6-N-acetylglucosamine (PNAG), lipopolysaccharide (LPS), and the enterobacterial common antigen (ECA). The highest levels of incorporation were observed in PGN with lower levels in PNAG and no observable incorporation in LPS or ECA. The promiscuity of the PNAG synthase (PgaCD) toward UDP-GlcNAz in vitro and the lack of undecaprenyl-pyrophosphoryl-GlcNAz intermediates generated in vivo confirmed the incorporation preferences. The results of this work will guide the future development of carbohydrate-based probes and metabolic engineering strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia coliLipopolysaccharidesAcetylglucosaminePolysaccharides, BacterialPeptidoglycanUridine Diphosphate

Substanzen

LipopolysaccharidesAcetylglucosaminePolysaccharides, BacterialPeptidoglycanUridine Diphosphate

Autor:innen und Institutionen

  • Department of Chemistry, University of Toronto, Toronto, Ontario M5S 3H6, Canada.
  • Department of Chemistry, University of North Carolina at Charlotte, Charlotte, North Carolina 28223-0001, United States.
  • Program in Molecular Medicine, The Hospital for Sick Children, Toronto, Ontario M5G 0A4, Canada.
  • Department of Biochemistry, University of Toronto, Toronto, Ontario M5G 0A4, Canada.

ORCID-Profile: Alexander Eddenden, Jerry M Troutman, Mark Nitz

Förderung

  • NIGMS NIH HHS
  • Canadian Institutes of Health Research
  • University of Toronto
  • Sick Kids Foundation
  • Natural Sciences and Engineering Research Council of Canada
  • National Institute of General Medical Sciences

Zitieren

APA

Eddenden, A., Dooda, M. K., Morrison, Z. A., Shankara Subramanian, A., Howell, P. L., Troutman, J. M., & Nitz, M. (2024). Metabolic Usage and Glycan Destinations of GlcNAz in E. coli. ACS Chemical Biology. https://doi.org/10.1021/acschembio.3c00501

Vancouver

Eddenden A, Dooda MK, Morrison ZA, Shankara Subramanian A, Howell PL, Troutman JM, et al. Metabolic Usage and Glycan Destinations of GlcNAz in E. coli. ACS Chemical Biology. 2024. doi:10.1021/acschembio.3c00501

BibTeX
@article{Eddenden2024,
  author = {Eddenden, Alexander and Dooda, Manoj K and Morrison, Zachary A and Shankara Subramanian, Adithya and Howell, P Lynne and Troutman, Jerry M and Nitz, Mark},
  title = {Metabolic Usage and Glycan Destinations of GlcNAz in E. coli},
  journal = {ACS Chemical Biology},
  year = {2024},
  doi = {10.1021/acschembio.3c00501}
}
Kostenlos starten →